Senzer Secures US Clinical Data Package for the Treatment of Chemotherapy Induced Adverse Events
London (ots/PRNewswire) - Senzer has secured the Investigational New Drug application and data package for its ongoing FDA registration programme from its former US strategic partner and will now push ahead to get its cannabinoid respiratory device approved for treating side effects induced by anti-cancer treatments ...
mehr